VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension

BACKGROUND: Pulmonary Arterial Hypertension (PAH) remains a therapeutic challenge, and the search continues for more effective drugs and drug combinations. We recently reported that deletion of the vasoactive intestinal peptide (VIP) gene caused the spontaneous expression of a PH phenotype that was...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hamidi, Sayyed A, Lin, Richard Z, Szema, Anthony M, Lyubsky, Sergey, Jiang, Ya Ping, Said, Sami I
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3210095/
https://ncbi.nlm.nih.gov/pubmed/22029879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares